Department of Biology, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark.
Human Movement Analysis Lab., Department of Orthopaedic Surgery, Copenhagen University Hospital, Amager-Hvidovre, Denmark.
Clin Biomech (Bristol). 2022 Aug;98:105714. doi: 10.1016/j.clinbiomech.2022.105714. Epub 2022 Jul 8.
Cerebral palsy (CP) is characterized by spasticity and muscle contracture development and associated with mild to severe motor impairments including reduced gait function. Treatment with the Exopulse® suit has been shown to reduce spasticity of the affected muscles and constitutes a non-invasive alternative to pharmaceutical agents and surgical denervation. The present study investigated the effect of systematic treatment with the Exopulse® suit on the nonlinear dynamics and variability of trunk accelerations during walking in children with unilateral CP.
Twelve patients (mean age: 12 years, range 7-17 years) with unilateral CP (GMFCS level 1 and 2) received 24 weeks Exopulse® suit treatment with patient-specific muscle stimulation. Before and after the treatment, the patients completed 4 min treadmill walking while trunk accelerometry was obtained. The nonlinear dynamics was quantified by the largest Lyapunov exponent and the complexity index from the multiscale entropy and movement variability was quantified by the root mean square ratio. Pre- vs post-treatment differences were evaluated by a paired Student's t-test.
The largest Lyapunov exponent (p-value = 0.041) and the complexity index (p-value = 0.030) of the acceleration in the anterior-posterior direction was significantly lower post-treatment. No other between-trial differences were observed.
The present study suggests that 24 weeks of Exopulse® suit treatment alters the nonlinear dynamics but not the variability of the trunk accelerations during walking in children with unilateral CP. The temporal structure of the trunk acceleration in the anterior-posterior direction was altered towards that of healthy individuals.
脑瘫(CP)的特征是痉挛和肌肉挛缩的发展,并伴有轻度至重度运动障碍,包括步态功能下降。已有研究表明,使用 Exopulse®服治疗可降低受影响肌肉的痉挛程度,是一种替代药物和手术去神经支配的非侵入性方法。本研究旨在探讨系统使用 Exopulse®服治疗对单侧 CP 儿童行走时躯干加速度非线性动力学和可变性的影响。
12 名单侧 CP 患儿(平均年龄 12 岁,范围 7-17 岁;GMFCS 分级 1 级和 2 级)接受了 24 周的 Exopulse®服治疗,采用针对特定肌肉的刺激。在治疗前后,患者在跑步机上行走 4 分钟,同时获取躯干加速度计数据。使用多尺度熵的最大 Lyapunov 指数和复杂度指数以及均方根比的运动可变性来量化非线性动力学。通过配对学生 t 检验评估治疗前后的差异。
治疗后,躯干加速度的最大 Lyapunov 指数(p 值=0.041)和复杂度指数(p 值=0.030)在前-后方向显著降低。未观察到其他试验间差异。
本研究表明,24 周的 Exopulse®服治疗改变了单侧 CP 儿童行走时躯干加速度的非线性动力学,但不改变其可变性。躯干加速度在前后方向的时间结构向健康个体的方向改变。